Lisa Mayr

4.2k total citations
25 papers, 239 citations indexed

About

Lisa Mayr is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lisa Mayr has authored 25 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 11 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lisa Mayr's work include Glioma Diagnosis and Treatment (15 papers), Brain Metastases and Treatment (6 papers) and Chromatin Remodeling and Cancer (4 papers). Lisa Mayr is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Brain Metastases and Treatment (6 papers) and Chromatin Remodeling and Cancer (4 papers). Lisa Mayr collaborates with scholars based in Austria, Germany and Netherlands. Lisa Mayr's co-authors include Walter Berger, Sushilla van Schoonhoven, Bernd Kubista, Reinhard Windhager, Daniela Lötsch, Christine Pirker, Andreas Peyrl, Johannes Gojo, Irene Slavc and Amedeo A. Azizi and has published in prestigious journals such as Neurosurgery, Acta Neuropathologica and Oncotarget.

In The Last Decade

Lisa Mayr

22 papers receiving 239 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Mayr Austria 9 121 77 71 50 43 25 239
Bipasha Mukherjee United States 4 165 1.4× 81 1.1× 101 1.4× 62 1.2× 61 1.4× 6 278
Leire Pedrosa Spain 8 81 0.7× 33 0.4× 79 1.1× 33 0.7× 58 1.3× 29 240
Laura M. McKay United States 5 103 0.9× 62 0.8× 113 1.6× 42 0.8× 48 1.1× 6 249
Malcolm Lim Australia 10 118 1.0× 33 0.4× 109 1.5× 87 1.7× 29 0.7× 20 236
Michaël H. Meel Netherlands 13 172 1.4× 153 2.0× 68 1.0× 41 0.8× 65 1.5× 20 367
Shirley Ong United States 8 66 0.5× 113 1.5× 92 1.3× 63 1.3× 33 0.8× 18 215
Zi-Fen Su Canada 8 88 0.7× 56 0.7× 104 1.5× 88 1.8× 54 1.3× 15 349
Pak Leng Cheong Australia 8 148 1.2× 83 1.1× 28 0.4× 32 0.6× 18 0.4× 17 321
Christina Schug Germany 14 174 1.4× 61 0.8× 71 1.0× 21 0.4× 43 1.0× 15 347
Chiaki Tsuge Ishida United States 10 281 2.3× 88 1.1× 66 0.9× 23 0.5× 104 2.4× 12 373

Countries citing papers authored by Lisa Mayr

Since Specialization
Citations

This map shows the geographic impact of Lisa Mayr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Mayr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Mayr more than expected).

Fields of papers citing papers by Lisa Mayr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Mayr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Mayr. The network helps show where Lisa Mayr may publish in the future.

Co-authorship network of co-authors of Lisa Mayr

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Mayr. A scholar is included among the top collaborators of Lisa Mayr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Mayr. Lisa Mayr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayr, Lisa, Amedeo A. Azizi, Johannes Gojo, & Andreas Peyrl. (2025). Medulloblastoma: Current Standard of Care and Future Treatment Opportunities. Pediatric Drugs. 28(1). 31–42.
2.
Mayr, Lisa, Maria T. Schmook, Adalbert Raimann, et al.. (2024). Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients. Pediatric Blood & Cancer. 71(3). e30836–e30836. 8 indexed citations
3.
Minichmayr, Iris K., Johannes Gojo, Daniel Senfter, et al.. (2024). Distribution of Bevacizumab into the Cerebrospinal Fluid of Children and Adolescents with Recurrent Brain Tumors. Pediatric Drugs. 26(4). 429–440. 1 indexed citations
4.
Patel, Priya, Lukas Haider, Tracey Taylor, et al.. (2024). Feasibility, tolerability, and first experience of intracystic treatment with peginterferon alfa-2a in patients with cystic craniopharyngioma. Frontiers in Oncology. 14. 1401761–1401761. 5 indexed citations
5.
Senfter, Daniel, Julia Furtner, Christine Haberler, et al.. (2023). Proof-of-Concept for Liquid Biopsy Disease Monitoring of MYC-Amplified Group 3 Medulloblastoma by Droplet Digital PCR. Cancers. 15(9). 2525–2525. 8 indexed citations
6.
Madlener, Sibylle, Julia Furtner, Daniel Senfter, et al.. (2023). Clinical applicability of miR517a detection in liquid biopsies of ETMR patients. Acta Neuropathologica. 145(6). 843–846. 3 indexed citations
7.
Mayr, Lisa, Sibylle Madlener, J.M. Berger, et al.. (2023). HGG-08. COMBINATORIAL ACTIVITY OF CDK4/6-INHIBITORS AND TRAMETINIB IN PEDIATRIC HIGH-GRADE GLIOMA WITH BRAFV600E MUTATION AND HOMOZYGOUS CDKN2A DELETION. Neuro-Oncology. 25(Supplement_1). i40–i40.
8.
Jäger, Walter, Stefan Poschner, Lisa Mayr, et al.. (2022). Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors. Cancer Chemotherapy and Pharmacology. 89(5). 617–627. 5 indexed citations
9.
Slavc, Irene, Lisa Mayr, Johannes Gojo, et al.. (2022). Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach. Cancers. 14(20). 5128–5128. 20 indexed citations
10.
Gojo, Johannes, Amedeo A. Azizi, Lisa Mayr, et al.. (2022). Prospective Evaluation of Kidney Function in Long-Term Survivors of Pediatric CNS Tumors. Current Oncology. 29(8). 5306–5315.
11.
Kirchhofer, Dominik, Lisa Mayr, Christine Pirker, et al.. (2021). CSIG-04. UNCOUPLING OF ETS1 FROM MAPK PATHWAY SIGNALS AS RESISTANCE MECHANISM TOWARDS BRAF INHIBITORS IN BRAF-MUTATED CHILDHOOD GLIOMA. Neuro-Oncology. 23(Supplement_6). vi33–vi34. 1 indexed citations
12.
Mayr, Lisa, Sibylle Madlener, Dominik Kirchhofer, et al.. (2021). CSIG-30. TARGETING TELOMERASE VIA MEK INHIBITION IN AGGRESSIVE TERT PROMOTER MUTATED BRAIN TUMORS. Neuro-Oncology. 23(Supplement_6). vi39–vi40. 1 indexed citations
13.
Mayr, Lisa, Sibylle Madlener, Maria T. Schmook, et al.. (2021). INNV-17. RESPONSE TO AVAPRITINIB IN A PEDIATRIC SPINAL CORD H3K27M-MUTANT GLIOMA PATIENT. Neuro-Oncology. 23(Supplement_6). vi108–vi108. 1 indexed citations
14.
Mayr, Lisa, Johannes Gojo, Andreas Peyrl, et al.. (2020). Potential Importance of Early Focal Radiotherapy Following Gross Total Resection for Long-Term Survival in Children With Embryonal Tumors With Multilayered Rosettes. Frontiers in Oncology. 10. 584681–584681. 14 indexed citations
15.
Peyrl, Andreas, Lisa Mayr, Bernhard Englinger, et al.. (2020). Cerebrospinal fluid penetration of targeted therapeutics in pediatric brain tumor patients. Acta Neuropathologica Communications. 8(1). 78–78. 31 indexed citations
16.
Lötsch, Daniela, Dominik Kirchhofer, Sushilla van Schoonhoven, et al.. (2019). TERT expression is susceptible to BRAF and ETS-factor inhibition in BRAFV600E/TERT promoter double-mutated glioma. Acta Neuropathologica Communications. 7(1). 128–128. 22 indexed citations
17.
Peyrl, Andreas, Amedeo A. Azizi, Johannes Gojo, et al.. (2018). EAPH-11. INTRAVENTRICULAR THERAPY ALTERNATING ETOPOSIDE, AQUEOUS CYTARABINE AND TOPOTECAN IS FEASIBLE AND SAFE: EXPERIENCE IN 26 PEDIATRIC PATIENTS WITH MALIGNANT BRAIN TUMORS. Neuro-Oncology. 20(suppl_2). i67–i67. 1 indexed citations
18.
Slavc, Irene, Andreas Peyrl, Monika Chocholous, et al.. (2018). MBCL-27. RESPONSE OF RECURRENT MALIGNANT CHILDHOOD CNS TUMORS TO A MEMMAT BASED METRONOMIC ANTIANGIOGENIC COMBINATION THERAPY VARIES DEPENDENT ON TUMOR TYPE: EXPERIENCE IN 71 PATIENTS. Neuro-Oncology. 20(suppl_2). i122–i122. 3 indexed citations
19.
Kubista, Bernd, Lisa Mayr, Sushilla van Schoonhoven, et al.. (2017). Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition. Journal of Experimental & Clinical Cancer Research. 36(1). 52–52. 26 indexed citations
20.
Sevelda, Florian, Lisa Mayr, Bernd Kubista, et al.. (2015). EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance. Journal of Experimental & Clinical Cancer Research. 34(1). 134–134. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bipasha Mukherjee Breakdown of academic impact, for papers by Leire Pedrosa Breakdown of academic impact, for papers by Laura M. McKay Breakdown of academic impact, for papers by Malcolm Lim Breakdown of academic impact, for papers by Michaël H. Meel Breakdown of academic impact, for papers by Shirley Ong Breakdown of academic impact, for papers by Zi-Fen Su Breakdown of academic impact, for papers by Pak Leng Cheong Breakdown of academic impact, for papers by Christina Schug Breakdown of academic impact, for papers by Chiaki Tsuge Ishida
Rankless by CCL
2026